医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Miho Biztech Launches Home Care Breast Massager Vitalbra

2023年10月24日 PM10:00
このエントリーをはてなブックマークに追加


 

DAEJEON, South Korea

Miho Biztech, a health and beauty equipment company, introduces Vitalbra, Korea’s exclusive all-in-one breast care product.

Vitalbra is a private breast care massager designed to complement breast volume and elasticity, helping to enhance breast elasticity, boost breast volume, and prevent breast aging. This beauty device employs both vacuum pressure and EMS low-frequency stimulation, helping customers achieve a healthy and beautiful feminine image at home by improving breast volume and elasticity easily and safely.

The massager uses powerful 3-level sound pressure to lift breast tissue and provides low-frequency massage to the target area to increase blood circulation and supply nutrients, improving volume and elasticity.

The patented double silicone dome, designed to complement the body’s curves, is exceptionally light at 380 grams, allowing customers to use it for long periods of time without the need for an auxiliary bra.

Vitalbra has been clinically validated for its elasticity-enhancing function, safety, and effectiveness, without adverse reactions. Furthermore, its unique double silicone technology with a 0.8-mm-thick natural silicone protection film minimizes adverse effects such as skin problems, even under high pressure.

Hong Eui-kwon, CEO of Miho Biztech Co., Ltd., said, “Miho Biztech developed Vitalbra, a multifunctional chest massager with a patented double silicone safety net, to address the stress caused by small breasts, a major concern for women worldwide who pursue beauty, as well as the inconvenience of adding thick bra pads, the fear of implant surgery, and the financial burden. We aspire to make it easier for all women to maintain and care for healthy, beautiful breasts at home.”

For more information about Miho Biztech, please visit its website: http://www.mihobth.com/.

View source version on businesswire.com: https://www.businesswire.com/news/home/20231024278222/en/

CONTACT

EDL ENTERPRISE for Miho Biztech Co., Ltd.

Sujin Lee

lsj@edl.co.kr

同じカテゴリーの記事 

  • Ifinatamab Deruxtecan Continues to Demonstrate Promising Objective Response Rates in Patients with Extensive-Stage Small Cell Lung Cancer in IDeate-Lung01 Phase 2 Trial
  • Huonslab Announces Positive Results from In Vivo comparative PK study of Trastuzumab/HyDIFFUZETM compared with marketed rHuPH20 co-formulation with Trastuzumab
  • Rapid Medical™、TIGERTRIEVER™13を用いたDISTALS臨床試験の中間安全性解析で、中血管閉塞の安全性の懸念がないことを報告
  • Amneal and Shilpa Announce U.S. FDA Approval of BORUZU™, the First Ready-to-Use Version of Bortezomib for subcutaneous administration
  • JCR Pharmaceuticals’ Data Presentations at SSIEM Annual Symposium 2024 Highlight Investigational Treatments for Lysosomal Storage Disorders